RGH-188, a D3/D2 dopamine receptor partial agonist antipsychotic candidate with excellent brain availability and low EPS liability

被引:0
|
作者
Gyertyan, Istvan [1 ]
Kiss, Bela [1 ]
Saghy, Katalin [1 ]
Pasztor, Gabriella [1 ]
Gemesi, Larisza I. [1 ]
Kapas, Margit [1 ]
Agai-Csongor, Eva [1 ]
Domany, Gyorgy [1 ]
Tihanyi, Karoly [1 ]
Szombathelyi, Zsolt [1 ]
机构
[1] Pharmacol & Drug Safety Res, Budapest, Hungary
关键词
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
244
引用
收藏
页码:76S / 76S
页数:1
相关论文
共 50 条
  • [1] RGH-188, a d3/d2 dopamine receptor antagonist/partial agonist atypical antipsychotic candidate
    Laszlovszky, I.
    Kiss, B.
    Gyertyan, I.
    Meszaros, G. Pasztor
    Seneca, N.
    Schmidt, E.
    Nemethy, Z. S.
    Bugovics, G. Y.
    Saghy, K.
    Laszy, J.
    Kapas, M.
    Nemeth, G. Y.
    Szombathelyi, Z. S.
    EUROPEAN PSYCHIATRY, 2008, 23 : S163 - S163
  • [2] Favourable behavioural actions of RGH-188, a novel dopamine D3/D2 receptor antagonist/partial agonist antipsychotic candidate
    Gyertyan, I.
    Kiss, B.
    Saghy, K.
    Laszy, J.
    Szabo, G.
    Agai-Csongor, E.
    Domany, G.
    Tihanyi, K.
    Szombathelyi, Z.
    BEHAVIOURAL PHARMACOLOGY, 2007, 18 : S12 - S13
  • [3] Pharmacological profile of RGH-188, a novel dopamine D3/D2 receptor antagonist/partial agonist atypical antipsychotic
    Gyertyan, I.
    Kiss, B.
    Saghy, K.
    Laszlovszky, I.
    Horvath, A.
    Laszy, J.
    Schmidt, E.
    Szabo, G.
    Domany, G.
    Csongor, E. Agai
    Tihanyi, K.
    Szombathelyi, Z.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S432 - S432
  • [4] Dopamine 1321133 receptor occupancy of RGH-188, a D3/D2 antagonist/partial agonist antipsychotic, in healthy volunteers
    Laszovszky, I.
    Nemeth, G.
    Meszaros, G. Pasztor
    Kapas, M.
    Brooks, D. J.
    Pavese, N.
    Szombathelyi, Z.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S455 - S455
  • [5] RGH-188, an atypical antipsychotic with dopamine D3/D2 antagonist/partial agonist properties:: In vitro characterisation
    Kiss, B.
    Laszlovszky, I.
    Horvath, A.
    Schmidt, E.
    Bugovics, Gy.
    Orosz, Sz.
    Hornok, K.
    Gyertyan, I.
    Agai-Csongor, E.
    Domany, Gy.
    Tihanyi, K.
    Szombathelyi, Zs.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S221 - S222
  • [6] Cariprazine (RGH-188), a Dopamine D3 Receptor-Preferring, D3/D2 Dopamine Receptor Antagonist-Partial Agonist Antipsychotic Candidate: In Vitro and Neurochemical Profile
    Kiss, Bela
    Horvath, Attila
    Nemethy, Zsolt
    Schmidt, Eva
    Laszlovszky, Istvan
    Bugovics, Gyula
    Fazekas, Karoly
    Hornok, Katalin
    Orosz, Szabolcs
    Gyertyan, Istvan
    Agai-Csongor, Eva
    Domany, Gyoergy
    Tihanyi, Karoly
    Adham, Nika
    Szombathelyi, Zsolt
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 333 (01): : 328 - 340
  • [7] RGH-188, an atypical antipsychotic with dopamine D3/D2 antagonist/partial agonist properties:: Neurochemical characterisation
    Kiss, B.
    Gyertyan, I.
    Agai-Csongor, E.
    Domany, Gy.
    Tihanyi, K.
    Szombathelyi, Zs.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S222 - S222
  • [8] RGH-188, an atypical antipsychotic with dopamine D3/D2 antagonist/partial agonist properties:: Behavioral characterisation
    Gyertyan, I.
    Kiss, B.
    Saghy, K.
    Laszy, J.
    Szabo, Gy.
    Agai-Csongor, E.
    Domany, Gy.
    Tihanyi, K.
    Szombathelyi, Zs.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S222 - S222
  • [9] Pharmacokinetics of RGH-188, a novel dopamine D3/D2 antagonist/partial agonist atypical antipsychotic, in rats and dogs
    Meszaros, G. Pasztor
    Bolf, E. Terjeki
    Gemesi, L.
    Kapas, M.
    Tihanyi, K.
    Szombathelyi, Z.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S456 - S457
  • [10] Pharmacokinetics of RGH-188, a new dopamine D3/D2 antagonist/partial agonist atypical antipsychotic, in healthy subjects
    Meszaros, G. Pasztor
    Kapas, M.
    Borsos, M.
    Laszlovszky, I.
    Nemeth, G.
    Tihanyi, K.
    Szombathelyi, Z.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S451 - S452